Results 61 to 70 of about 21,764,403 (203)
The aim of this commentary is to investigate the interplay of Biopharmaceutics Classification System (BCS), Biopharmaceutics Drug Disposition Classification System (BDDCS) and Salivary Excretion Classification System (SECS). BCS first classified drugs based on permeability and solubility for the purpose of predicting oral drug absorption.
openaire +2 more sources
Use of the Biopharmaceutical Classification System in Early Drug Development [PDF]
The Biopharmaceutics Classification System (BCS) is not only a useful tool for obtaining waivers for in-vivo bioequivalence studies but also for decision making in the discovery and early development of new drugs. Measurement of solubility and permeability in the discovery/development settings is described.
openaire +2 more sources
This study develops a smart glove by integrating a P(BZMA‐co‐HEA)/IL ionogel with a reconfigurable FPCB for underwater communication and real‐time safety warning. The network‐constrained ionic soft‐space regulation strategy enables mechanical reliability, environmental stability, and sensing adaptability, while the modular FPCB sensor array simplifies ...
Xiaoqin Li +8 more
wiley +1 more source
Zinc‐functionalized calcium phosphate microparticles guide bone regeneration phases by providing phase‐matched ion availability. Early Zn2+ release modulates inflammation, cell recruitment, and supports angiogenic signaling, while sustained Ca2+ and PO43− supply drives osteogenesis.
Hyewoo Jeong +6 more
wiley +1 more source
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development
Omri Wolk, Riad Agbaria, Arik Dahan Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel Abstract: The main objective of this work was to investigate in-silico ...
Wolk O, Agbaria R, Dahan A
doaj
In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma
By employing in vivo CRISPR functional screening, we identify ribosomal protein RPS19 as a pivotal mediator driving immune evasion in hepatocellular carcinoma, wherein tumor‑released RPS19 binds C5aR1 on tumor‑associated macrophages to initiate downstream immunosuppressive signaling; SP94‑peptide‑modified SNPSS nanoparticles deliver Cas9/sgRPS19 ...
Lei He +20 more
wiley +1 more source
ReLink: Reliable Deep Learning for Microscopic Motion Tracking
ReLink enables reliable trajectory linking in single‐particle tracking by integrating physics‐informed motion statistics with confidence‐based adaptive filtering. Across diverse simulated and experimental conditions, ReLink robustly reconstructs trajectories and preserves the fidelity of downstream analyses, enabling accurate characterization of ...
Yuan Jiang +7 more
wiley +1 more source
DNA‐PKcs–DNMT3A Axis Triggers Aging‐Like Deteriorations in Mouse Pluripotent Stem Cells
Lamin A‐mediated phosphorylation of DNA‐PKcs supports efficient DNA repair and proper SP1/3‐mediated transcription of Dnmt3a. During iPSC passaging, reduced Lamin A destabilizes the genome and lowers Dnmt3a expression by inactivating DNA‐PKcs, leading to derepression of developmental and somatic programs that mimics aging and impairs iPSC ...
Xiaoyu Xu +10 more
wiley +1 more source
Objectives: Herpetrione (HPE) is a bioactive lignan recognized for its hepatoprotective properties; however, it exhibits limited oral bioavailability.
Fang Wang +5 more
doaj +1 more source
Biopharmaceutical Classification System (BCS)
A BCS-based biowaiver for generic drugs requires high drug solubility throughout the physiological pH range plus identical product quality and near-identical reference product content to meet recommendation standards outlined by the 2017 FDA Guidance.
Viraj Anant Nagare, Sakshi uttam Kadam
openaire +1 more source

